Stress Ulcer Prophylaxis
- 1 July 2016
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 44 (7), 1395-1405
- https://doi.org/10.1097/ccm.0000000000001872
Abstract
Objectives: Stress ulcer prophylaxis is commonly administered to critically ill patients for the prevention of clinically important stress-related mucosal bleeding from the upper gastrointestinal tract. Despite widespread incorporation of stress ulcer prophylaxis into practice around the world, questions are emerging about its indications and impact. This clinically focused article will review current controversies related to stress ulcer prophylaxis for critically ill adult patients, including bleeding frequency, risk factors, comparative efficacy, adverse effect profile, and overall cost-effectiveness of the available stress ulcer prophylaxis regimens. Data Sources: A MEDLINE search was conducted from inception through August 2015. Study Selection: Selected publications describing stress ulcer prophylaxis in adult patients were retrieved (original research, systematic reviews, and practice guidelines); their bibliographies were also reviewed to identify additional pertinent-publications. Data Extraction: Data from relevant publications were abstracted and summarized. Data Synthesis: The existing evidence is organized to describe the patients most likely to benefit from stress ulcer prophylaxis, review the comparative efficacy of proton pump inhibitors and histamine 2 receptor antagonists, the adverse effects of stress ulcer prophylaxis, and overall cost-effectiveness. Conclusions: Many stress ulcer prophylaxis recommendations are based on older studies at risk of bias, which may not be applicable to modern practice. Stress ulcer prophylaxis should be limited to patients considered to be at high risk for clinically important bleeding. When evaluating only the trials at low risk for bias, the evidence does not clearly support lower bleeding rates with proton pump inhibitors over histamine 2 receptor antagonists; however, proton pump inhibitors appear to be the dominant drug class used worldwide today. The current rate of upper gastrointestinal bleeding and the relative adverse effects of acid suppression on infectious risk may drive not only the effectiveness, but also the cost-effectiveness of stress ulcer prophylaxis today. Research is currently underway to better address these issues.Keywords
This publication has 81 references indexed in Scilit:
- Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill PatientsCritical Care Medicine, 2013
- Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infectionAlimentary Pharmacology & Therapeutics, 2011
- Development and Validation of a Clostridium difficile Infection Risk Prediction ModelInfection Control & Hospital Epidemiology, 2011
- Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysisCMAJ : Canadian Medical Association Journal, 2010
- Postoperative Clostridium difficile-associated diarrheaSurgery, 2010
- Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trialsCritical Care, 2010
- Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical ImplicationsDigestive Diseases and Sciences, 2009
- Acid-Suppressive Medication Use and the Risk for Hospital-Acquired PneumoniaJAMA, 2009
- A Review of Stress Ulcer ProphylaxisJournal of Pharmacy Practice, 2002